Infectious complications of tumor necrosis factor-α antagonists

被引：24

作者：

Bakleh, M ^{[1
]}

Tleyjeh, I ^{[1
]}

Matteson, EL ^{[1
]}

Osmon, DR ^{[1
]}

Berbari, EF ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Div Infect Dis & Rheumatol, Dept Internal Med, Coll Med, Rochester, MN 55905 USA

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 2005年 / 44卷 / 06期

关键词：

D O I：

10.1111/j.1365-4632.2004.02571.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：443 / 448

页数：6

共 59 条

[1]

*ABB LAB, 2004, HUM

[2] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].

Bathon, JM ;

Martin, RW ;

Fleischmann, RM ;

Tesser, JR ;

Schiff, MH ;

Keystone, EC ;

Genovese, MC ;

Wasko, MC ;

Moreland, LW ;

Weaver, AL ;

Markenson, J ;

Finck, BK .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593

[3] Shingles following infliximab infusion [J].

Baumgart, DC ;

Dignass, AU .

ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) :661-661

[4]

Bean AGD, 1999, J IMMUNOL, V162, P3504

[5] Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis -: An open, observational, extension study of a three-month, randomized, placebo-controlled trial [J].

Braun, J ;

Brandt, J ;

Listing, J ;

Zink, A ;

Alten, R ;

Burmester, G ;

Golder, W ;

Gromnica-Ihle, E ;

Kellner, H ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Reddig, J ;

Sieper, J .

ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2224-2233

[6] Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].

Braun, J ;

Brandt, J ;

Listing, J ;

Zink, A ;

Alten, R ;

Golder, W ;

Gromica-Ihle, E ;

Kellner, H ;

Krause, A ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Thriene, W ;

Sieper, J .

LANCET, 2002, 359 (9313) :1187-1193

[7]

*CENT INC, 2004, REM

[8] IMPORTANCE OF ENDOGENOUS TUMOR-NECROSIS-FACTOR-ALPHA AND GAMMA-INTERFERON IN HOST-RESISTANCE AGAINST PNEUMOCYSTIS-CARINII INFECTION [J].

CHEN, WX ;

HAVELL, EA ;

HARMSEN, AG .

INFECTION AND IMMUNITY, 1992, 60 (04) :1279-1284

[9] The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients [J].

Colombel, JF ;

Loftus, EV ;

Tremaine, WJ ;

Egan, LJ ;

Harmsen, WS ;

Schleck, CD ;

Zinsmeister, AR ;

Sandborn, WJ .

GASTROENTEROLOGY, 2004, 126 (01) :19-31

[10] Recombinant human tumor necrosis factor receptor, (etanercept) for treating ankylosing spondylitis - A randomized, controlled trial [J].

Davis, JC ;

van der Heijde, D ;

Braun, J ;

Dougados, M ;

Cush, J ;

Clegg, DO ;

Kivitz, A ;

Fleischmann, R ;

Inman, R ;

Tsuji, W .

ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3230-3236

← 1 2 3 4 5 6 →